News | April 22, 2011

Two Top Cancer Centers Install Robotic Patient Positioning System

 Hexapod on Pedestal 6 rgb

 

The Moores Cancer Center in San Diego, Calif., and Zurich University, Zurich, Switzerland, have both installed CIVCO Medical Solutions' Protura Robotic Patient Positioning System and Universal Couchtop (UCT).

Additionally, CIVCO recently entered into a joint interface agreement with Varian Medical Systems regarding Protura and UCT. Each device is now validated for use with Varian's Clinac and Trilogy platforms, offering an advanced robotics option for Varian Exact treatment couches. CIVCO currently has 8 robotic systems installed on Varian linear accelerators and several more pending installations.

"This is a significant milestone in the development of Protura," said Mike Saracen, vice president, advanced robotics and IGRT solutions at CIVCO. "We are pleased to offer this solution complementing Varian's dynamic, versatile Clinac platform. Protura provides customers with the benefits of precision robotic positioning to meet the motion management demands of IGRT."

Protura's ability to interface with existing IGRT-enabled linacs supports sub-millimeter patient positioning and corrections with 6 degrees of freedom. This, along with the interface-supporting automation is the ideal solution for streamlining throughput and enabling more accurate treatments.

"Varian is committed to providing an open architecture for our treatment delivery solutions," said Corey Zankowski, senior director of product management at Varian. "We want to give our customers the flexibility to adopt new and advanced technologies that best meet the needs of the clinic and their patients."

"The Protura 6 degree of freedom robotic treatment couch is the next step in correcting the patient's position prior to treatment," said Todd Pawlicki, director of physics and clinical operations at Moores Cancer Center. "Motion management in conjunction with Protura has the potential to open the door to real-time patient position adjustments during treatment for increased accuracy during extended treatments."

The lightweight UCT is IGRT friendly and features compatibility with Body Pro-Lok bridges for comfortable and rigid immobilization for hypofractionation, low attenuation and DoseMatch Technology for easy transitions between simulation and treatment.

For more information: www.civco.com

Related Content

Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).

Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline). See more figures from this study.

Feature | Radiation Therapy | September 28, 2021
September 28, 2021 — New research from Washington University School of Medicine in St.
The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%

Varian's Ethos artificial intelligence radiotherapy device.

News | Radiation Oncology | September 28, 2021
September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...